New shot shows promise against tough lung cancer
NCT ID NCT06883630
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests an experimental drug called RC148, given as an injection, in people with advanced non-small cell lung cancer that has spread. The study looks at how well the drug shrinks tumors, either alone or combined with other treatments. About 121 adults aged 18-80 with good performance status are enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Cancer Hospital of Guangxi Medical University
Nanning, Guangxi, China
-
Beijing Tiantan Hospital of Capital Medical University
Beijing, Beijing Municipality, China
-
Binzhou Medical University Hospital
Binzhou, Shandong, China
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
-
Henan cancer hospital
Zhengzhou, Henan, China
-
Hunan Cancer Hospital
Changsha, Hunan, China
-
Jiangmen Central Hospital
Jiangmen, Guangdong, China
-
Jinan Central Hospital
Jinan, Shandong, China
-
Linyi Cancer Hospital
Linyi, Shandong, China
-
Nanyang Second General Hospital
Hanyang, Henan, China
-
Peking University Cancer Hospital
Beijing, Beijing Municipality, China
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
-
Shunde Hospital of Southern Medical University
Foshan, Guangdong, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
-
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China
-
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
-
The First Affiliated Hospital of Xinxiang Medical College
Xinxiang, Henan, China
-
The First People's Hospital of Shunde
Foshan, Guangdong, China
-
The First affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
-
The Second Affiliated Hospital of Guilin Medical College
Gulin, Guangxi, China
-
Tianjin Medical University Cancer Institute Hospital
Tianjin, Tianjin Municipality, China
-
Union Hospital Tongji Medical College Huazhong University Of Science And Technologe
Wuhan, Hubei, China
-
Yunnan Cancer Hospital
Kunming, Yunnan, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?